CA Patent

CA2978736A1 — Dosing regimen of tradipitant

Assigned to Vanda Pharmaceuticals Inc · Expires 2016-09-09 · 10y expired

What this patent protects

This application relates to a method of treatment with tradipitant, and more particularly, to a method of treatment of pruritus with tradipitant

USPTO Abstract

This application relates to a method of treatment with tradipitant, and more particularly, to a method of treatment of pruritus with tradipitant

Drugs covered by this patent

Patent Metadata

Patent number: CA2978736A1
Jurisdiction: CA
Classification: —
Expires: 2016-09-09
Drug substance claim: No
Drug product claim: No
Assignee: Vanda Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.